RESUMO
Testosterone doping in sports is detected through the measurement of the carbon isotopic signature (δ13 C) of testosterone and its metabolites in urine. A critical step in achieving accurate and precise δ13 C values during compound-specific stable carbon isotope analysis (CSIA) is the removal of interfering matrix components. To this end, the World Anti-Doping Agency (WADA) recommends the use of high-performance liquid chromatography (HPLC) as a method of sample pretreatment. We provide a description of an automated two-dimensional HPLC (2D-HPLC) purification method for urine extracts that has made possible the CSIA of underivatized steroids, requiring only 36 min per sample. Eight urinary steroids including testosterone (T) and dehydroepiandrosterone (DHEA) and four of their metabolites as well as two endogenous reference compounds were collected during HPLC purification. Comparative GC chromatograms are used to contrast the efficiency of two-dimensional (2D) purification to a previously established 1D-HPLC method. The 2D purification leads to improved sample purity while simultaneously decreasing the analysis time, allowing for unprecedented sample throughput. Precision of δ13 C for all analyzed compounds in negative and positive controls was 0.5 or better, which is comparable with the precision of pure reference materials at similar intensities.
Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Desidroepiandrosterona/urina , Doping nos Esportes/prevenção & controle , Testosterona/urina , Isótopos de Carbono/urina , Cromatografia Gasosa , Desidroepiandrosterona/metabolismo , Feminino , Humanos , Masculino , Testosterona/metabolismo , Fatores de TempoRESUMO
The aim of this work was to validate the gas chromatography/combustion/isotope ratio mass spectrometry method in Havana Antidoping Laboratory and verify its implementation with a study of the Cuban population. The method was precise and accurate inside the linear working range; the limit of quantification and the uncertainty were compliant with TD2019IRMS. The study of the Cuban population showed no differences in δ13 C values between females and males. Only three values of Δδ13 C showed significant differences between sexes (PD-T, OHA-T, and 11-keto-Et-T). The values of δ13 C between -17.8 and -21.2 (upper and lower limits based on normal distribution) were consistent with other populations where C4 plant derivatives prevail in the diet.
Assuntos
Esteroides/urina , Detecção do Abuso de Substâncias/métodos , Adulto , Atletas , Isótopos de Carbono/urina , Cuba , Doping nos Esportes , Feminino , Cromatografia Gasosa-Espectrometria de Massas/métodos , Humanos , Limite de Detecção , Masculino , Adulto JovemRESUMO
Twenty-two pharmaceutical formulations containing prednisolone or prednisone commercially available in Italy, Belgium, Spain, Brazil, and India were analyzed through a specific gas chromatography combustion isotope ratio mass spectrometry (GC-C-IRMS) method. All of them showed typical non-endogenous δ13 C values, except for the Belgian nasal spray, Sofrasolone®, with a less depleted 13 C content (-17.84 ± 0.18). Observational studies were performed on two volunteers in therapy with Sofrasolone® to confirm the applicability of the method and to suggest adequate interpretation criteria also in the case of drugs with less negative δ13 C values. Urine samples were collected before, during, and within the 36 hours after the administration of the spray. Both δ13 C values and urinary concentrations of prednisolone and prednisone were evaluated. All samples were subjected to an adequate pre-treatment (enzymatic hydrolysis, liquid/liquid extraction, and two sequential HPLC steps) before injection to the GC-C-IRMS instrument, according to the method recently developed and validated in our laboratory. Pregnanediol (PD), tetrahydro-11-deoxycortisol (THS), and pregnanetriol (PT) were selected as endogenous reference compounds (ERC). The excretion profile was estimated through liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) method used routinely for the quali-quantitative detection of glucocorticoids. δ13 C values and urinary levels of prednisolone and prednisone were also determined after the intake of one single vial of Sintredius®, a prednisolone oral formulation with a conventional more negative δ13 C value (-29.28 ± 0.25). Finally, the potential masking effect that combined therapy with Sofrasolone® and Sintredius® could induce on the IRMS findings was investigated.
Assuntos
Isótopos de Carbono/urina , Doping nos Esportes/prevenção & controle , Composição de Medicamentos/métodos , Prednisolona/urina , Prednisona/urina , Detecção do Abuso de Substâncias/métodos , Administração Intranasal , Administração Oral , Adulto , Doping nos Esportes/métodos , Composição de Medicamentos/normas , Feminino , Cromatografia Gasosa-Espectrometria de Massas/métodos , Cromatografia Gasosa-Espectrometria de Massas/normas , Humanos , Masculino , Prednisolona/administração & dosagem , Prednisolona/química , Prednisona/administração & dosagem , Prednisona/química , Detecção do Abuso de Substâncias/normas , Adulto JovemRESUMO
Carbon isotope ratio (CIR) confirmation is one of the most complex and delicate analyses in the doping control field, due to the nature of the molecules to be confirmed, normally present in urinary samples as a consequence of an endogenous production. The requirements for method validation established by the World Anti-Doping Agency (WADA) have been pushing the accredited laboratories to improve their methods. The choice of the method is always a cost benefit ratio involving a hard-working and time-consuming analysis and the guarantee of reporting of reliable results. This work presents the method fully validated by the Brazilian Doping Control Laboratory as part of the preparation for the Rio de Janeiro Summer Olympic and Paralympic Games 2016. Sample preparation encompassed solid-phase extraction, liquid-liquid extraction, enzymatic hydrolysis, acetylation, and purification by preparative high-performance liquid chromatography, and analyses were performed by gas chromatography/combustion/isotope ratio mass spectrometry. This proved to be a robust method to CIR confirmation in a big event, as demonstrated by the analysis of 179 samples during the Games 2016, from clearly negative results and adverse findings for testosterone (T) and related substances, boldenone and its metabolite, 19-norandrosterone and formestane. Two atypical findings were also reported for T and metabolites.
Assuntos
Isótopos de Carbono/urina , Doping nos Esportes , Cromatografia Gasosa-Espectrometria de Massas/métodos , Congêneres da Testosterona/urina , Acetilação , Brasil , Cromatografia Líquida de Alta Pressão , Estranos/urina , Humanos , Extração Líquido-Líquido , Reprodutibilidade dos Testes , Extração em Fase Sólida , Esportes , Testosterona/análogos & derivados , Testosterona/urinaRESUMO
The impact of dehydroepiandrosterone (DHEA) administration has been widely studied for anti-doping purposes in men, whereas only a few studies have been performed in women. In the present study, the impact of DHEA on the steroid profile parameters and their carbon isotopic ratios was explored. Eleven healthy young women and 10 healthy young men received two treatments: One with 100 mg/day of DHEA for 28 days and one with a placebo according to a double-blind crossover protocol. Urine and saliva (only in females) samples were collected before and for 72 hours after each short-term treatment. In all female subjects, concentrations of the urinary parameters of the steroid profile were highly impacted by short-term DHEA administration including epitestosterone (E). Gas chromatography-combustion-isotope ratio mass spectrometry (GC-C-IRMS) analysis was performed and positive results were observed for E in the four female subjects where E concentration was adequate for such analysis, whereas men results remained negative for E. Last, the ability of the Anti-Doping Administration and Management System (ADAMS) software used for the athlete biological passport to identify such doping was assessed. Of the 11 passports generated for female subjects, 10 were automatically classified as an atypical passport finding (ATPF). For the remaining passport with normal status in one woman, the variability of the concentrations prevented the ADAMS software from adjusting individual limits. The most impacted markers in women were T/E and 5αAdiol/E, with a detection window of 36 hours for 5αAdiol/E. In addition, good correlations were observed for DHEA and T concentrations in urine and saliva in females.
Assuntos
Desidroepiandrosterona/administração & dosagem , Cromatografia Gasosa-Espectrometria de Massas/métodos , Saliva/química , Esteroides/análise , Esteroides/urina , Detecção do Abuso de Substâncias/métodos , Adulto , Biomarcadores/análise , Biomarcadores/urina , Isótopos de Carbono/análise , Isótopos de Carbono/urina , Desidroepiandrosterona/análise , Desidroepiandrosterona/urina , Doping nos Esportes , Método Duplo-Cego , Epitestosterona/análise , Epitestosterona/urina , Feminino , Humanos , Masculino , Testosterona/análise , Testosterona/urina , Adulto JovemRESUMO
High-precision carbon isotope ratio analysis of urinary steroids by gas chromatography-combustion-isotope ratio mass spectrometry (GC-C-IRMS) is the official test to detect illicit doping of synthetic versions of endogenous steroids, such as testosterone. Our group created the first steroid isotopic standards (SIS) specifically for World Anti-Doping Agency (WADA) accredited laboratories. The standards contain mixtures of steroids as acetates or free steroids at ~400 µg each per ampoule and have been widely distributed to anti-doping laboratories to facilitate comparability of inter-laboratory results. Here we report on the creation and characterization of 3 new high-volume single component SIS suitable for use as working standards. They contain ~50 times more steroid mass per ampoule than previous SIS. The new SIS, coded CU/PCC 40-1, CU/PCC 41-1, & CU/PCC 42-1, contain ~20 mg of androsterone, androsterone-AC, and 5α-cholestane, with determined isotopic values of -27.09 ± 0.07 mUr, -32.82 ± 0.01 mUr, -25.03 ± 0.01 mUr, respectively. We used our previously developed protocol to calibrate the isotopically uniform steroids against the isotopic standard gases methane and ethane in NIST RM 8559 that are traceable to the international standard Vienna PeeDee Belemnite (VPDB). Two sets of data, acquired 7 months apart, of absolute δ13 CVPDB and ∆Δδ13 CVPDB values from 8 randomly selected ampoules of all 3 SIS indicate uniformity of steroid isotopic composition within measurement reproducibility, SD(δ13 C) < 0.2 mUr Our results show that protocols for SIS extend to creation of high volume working standards that can also be used as internal standards under appropriate GC conditions.
Assuntos
Isótopos de Carbono/urina , Cromatografia Gasosa-Espectrometria de Massas/métodos , Esteroides/urina , Detecção do Abuso de Substâncias/métodos , Calibragem , Isótopos de Carbono/análise , Isótopos de Carbono/normas , Doping nos Esportes , Cromatografia Gasosa-Espectrometria de Massas/normas , Humanos , Padrões de Referência , Reprodutibilidade dos Testes , Esteroides/análise , Esteroides/normas , Detecção do Abuso de Substâncias/normasRESUMO
Measuring carbon isotope ratios (CIRs) of urinary analytes represents a cornerstone of doping control analysis and has been particularly optimized for the detection of the misuse of endogenous steroids. Isotope ratio mass spectrometry (IRMS) of appropriate quality, however, necessitates adequate purities of the investigated steroids, which requires extensive pre-analytical sample clean-up steps due to both the natural presence of the target analytes and the high complexity of the matrix. In order to accelerate the sample preparation and increase the automation of the process, the use of multidimensional gas chromatography (MDGC) prior to IRMS experiments, was investigated. A well-established instrumental configuration based on two independent GC ovens and one heart-cutting device was optimized. The first dimension (1D) separation was obtained by a non-polar column which assured high efficiency and good loading capacity, while the second dimension (2D), based on a mid-polar stationary phase, provided good selectivity. A flame ionization detector monitored the 1D, and the 2D was simultaneously recorded by isotope ratio and quadrupole mass spectrometry. The assembled MDGC set-up was applied for measuring testosterone, 5α- and 5ß-androstanediol, androsterone, and etiocholanolone as target compounds and pregnanediol as endogenous reference compound. The urine sample were pretreated by conventional sample preparation steps comprising solid-phase extraction, hydrolysis, and liquid-liquid extraction. The extract obtained was acetylated and different aliquots were injected into the MDGC system. Two high performance liquid chromatography steps, conventionally adopted prior to CIR measurements, were replaced by the MDGC approach. The obtained values were consistent with the conventional ones. Copyright © 2016 John Wiley & Sons, Ltd.
Assuntos
Anabolizantes/urina , Androsterona/urina , Isótopos de Carbono/urina , Cromatografia Líquida de Alta Pressão/métodos , Etiocolanolona/urina , Cromatografia Gasosa-Espectrometria de Massas/métodos , Esteroides/análise , Testosterona/urina , Anabolizantes/química , Androsterona/análise , Androsterona/química , Cromatografia Gasosa , Doping nos Esportes , Etiocolanolona/análise , Etiocolanolona/química , Humanos , Espectrometria de Massas , Esteroides/química , Esteroides/metabolismo , Testosterona/análiseRESUMO
BACKGROUND: Gastrointestinal (GI) and non-GI disorders are associated with altered intestinal permeability, which can be measured in vivo by urinary excretion after oral lactulose and mannitol ingestion. Inadvertent dietary consumption of (12) Carbon ((12) C, regular) mannitol in food or from other sources may interfere with the test's interpretation. (13) Carbon ((13) C) constitutes 1% of carbon in nature and (13) C mannitol is a stable isotope. Our aim was to determine the performance of (13) C mannitol for measurement of intestinal permeability. METHODS: Ten healthy volunteers underwent intestinal permeability assay using coadministered (12) C mannitol, (13) C mannitol and lactulose, followed by timed urine collections. Urinary sugar concentrations were measured using tandem high performance liquid chromatography-mass spectrometry. KEY RESULTS: We found that (13) C mannitol can be distinguishable from (12) C mannitol on tandem mass spectrometry. In addition, (13) C mannitol had ~20-fold lower baseline contamination compared to (12) C mannitol. We describe here the (13) C mannitol assay method for the measurement of intestinal permeability. CONCLUSIONS & INFERENCES: In conclusion, (13) C mannitol is superior to (12) C mannitol for measurement of intestinal permeability. It avoids issues with baseline contamination and erratic excretions during the testing period.
Assuntos
Isótopos de Carbono/metabolismo , Isótopos de Carbono/urina , Absorção Intestinal/fisiologia , Manitol/metabolismo , Manitol/urina , Biomarcadores/metabolismo , Biomarcadores/urina , Isótopos de Carbono/administração & dosagem , Humanos , Absorção Intestinal/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Masculino , Manitol/administração & dosagem , Pessoa de Meia-Idade , Permeabilidade/efeitos dos fármacos , Espectrometria de Massas em Tandem/métodosRESUMO
The natural carbon isotopic composition of acetone in urine was measured in healthy subjects using gas chromatography-combustion-isotope ratio mass spectrometry combined with headspace solid-phase microextraction (HS-SPME-GC-C-IRMS). Before applying the technique to a urine sample, we optimized the measurement conditions of HS-SPME-GC-C-IRMS using aqueous solutions of commercial acetone reagents. The optimization enabled us to determine the carbon isotopic compositions within ±0.2 of precision and ±0.3 of error using 0.05 or 0.2 mL of aqueous solutions with acetone concentrations of 0.3-121 mg/L. For several days, we monitored the carbon isotopic compositions and concentrations of acetone in urine from three subjects who lived a daily life with no restrictions. We also monitored one subject for 3 days including a fasting period of 24 h. These results suggest that changes in the availability of glucose in the liver are reflected in changes in the carbon isotopic compositions of urine acetone. Results demonstrate that carbon isotopic measurement of metabolites in human biological samples at natural abundance levels has great potential as a tool for detecting metabolic changes caused by changes in physiological states and disease.
Assuntos
Acetona/urina , Isótopos de Carbono/urina , Cromatografia Gasosa-Espectrometria de Massas/métodos , Acetona/química , Jejum , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Microextração em Fase Sólida , Temperatura , Coleta de Urina/métodos , Adulto JovemRESUMO
Isotope ratio mass spectrometry (IRMS) is applied to confirm testosterone (T) abuse by determining the carbon isotope ratios (δ(13)C value). However, (13)C labeled standards can be used to control the δ(13)C value and produce manipulated T which cannot be detected by the current method. A method was explored to remove the (13)C labeled atom at C-3 from the molecule of androsterone (Andro), the metabolite of T in urine, to produce the resultant (A-nor-5α-androstane-2,17-dione, ANAD). The difference in δ(13)C values between Andro and ANAD (Δδ(13)CAndro-ANAD, ) would change significantly in case manipulated T is abused. Twenty-one volunteers administered T manipulated with different (13)C labeled standards. The collected urine samples were analyzed with the established method, and the maximum value of Δδ(13)CAndro-ANAD post ingestion ranged from 3.0 to 8.8. Based on the population reference, the cut-off value of Δδ(13)CAndro-ANAD for positive result was suggested as 1.2. The developed method could be used to detect T manipulated with 3-(13)C labeled standards.
Assuntos
Espectrometria de Massas/métodos , Testosterona/urina , Adulto , Isótopos de Carbono/urina , Humanos , Limite de Detecção , Masculino , Detecção do Abuso de Substâncias/métodos , Adulto JovemRESUMO
This paper describes various methodological aspects that were encountered during the development of a system to monitor the in vivo behaviour of a newly developed colon delivery device that enables oral drug treatment of inflammatory bowel diseases. [(13)C]urea was chosen as the marker substance. Release of [(13)C]urea in the ileocolonic region is proven by the exhalation of (13)CO2 in breath due to bacterial fermentation of [(13)C]urea. The (13)CO2 exhalation kinetics allows the calculation of a lag time as marker for delay of release, a pulse time as marker for the speed of drug release and the fraction of the dose that is fermented. To determine the total bioavailability, also the fraction of the dose absorbed from the intestine must be quantified. Initially, this was done by calculating the time-dependent [(13)C]urea appearance in the body urea pool via measurement of (13)C abundance and concentration of plasma urea. Thereafter, a new methodology was successfully developed to obtain the bioavailability data by measurement of the urinary excretion rate of [(13)C]urea. These techniques required two experimental days, one to test the coated device, another to test the uncoated device to obtain reference values for the situation that 100 % of [(13)C]urea is absorbed. This is hampered by large day-to-day variations in urea metabolism. Finally, a completely non-invasive, one-day test was worked out based on a dual isotope approach applying a simultaneous administration of [(13)C]urea in a coated device and [(15)N2]urea in an uncoated device. All aspects of isotope-related analytical methodologies and required calculation and correction systems are described.
Assuntos
Colo/metabolismo , Sistemas de Liberação de Medicamentos , Ureia/farmacocinética , Algoritmos , Testes Respiratórios , Dióxido de Carbono/metabolismo , Isótopos de Carbono/sangue , Isótopos de Carbono/farmacocinética , Isótopos de Carbono/urina , Humanos , Modelos Biológicos , Isótopos de Nitrogênio/sangue , Isótopos de Nitrogênio/farmacocinética , Isótopos de Nitrogênio/urina , Ureia/sangue , Ureia/urinaRESUMO
The legally defensible proof of the abuse of endogenous steroids in sports is currently based on carbon isotope ratio mass spectrometry (IRMS), i.e. a comparison between (13)C/(12)C ratios of diagnostic precursors and metabolites of testosterone. The application of this technique requires a chromatographic baseline separation of respective steroids prior to IRMS detection and hence laborious sample pre-processing of the urinary steroid extracts including clean up by solid-phase extraction and/or liquid chromatography. Consequently, an efficient pre-selection of suspicious control urine samples is essential for appropriate follow up confirmation by IRMS and effective doping control. Two single transdermal administration studies of testosterone (50 mg Testogel® and Testopatch® at 3.8 mg in 16 h, respectively) were conducted and resulting profiles of salivary testosterone and urinary steroid profiles and corresponding carbon isotope ratios were determined. Conventional doping control markers (testosterone/epitestosterone ratio, threshold concentrations of androsterone, etiocholanolone, or androstanediols) did not approach or exceed critical thresholds. In contrast to these moderate variations, the testosterone concentration in oral fluid increased from basal values (30-142 pg/mg) to peak concentrations above 1000 pg/mg. It is likely that this significant increase in oral fluid is due to a pulsatile elevation of free (protein unbound) circulating testosterone after transdermal administration and may be assumed to represent a more diagnostic marker for transdermal testosterone administration.
Assuntos
Saliva/química , Detecção do Abuso de Substâncias , Testosterona/análise , Testosterona/urina , Administração Cutânea , Isótopos de Carbono/análise , Isótopos de Carbono/urina , Doping nos Esportes , Humanos , Masculino , Espectrometria de Massas/métodos , Pessoa de Meia-Idade , Detecção do Abuso de Substâncias/métodos , Testosterona/administração & dosagemRESUMO
PURPOSE: Meat and fish consumption are associated with changes in the risk of chronic diseases. Intake is mainly assessed using self-reporting, as no true quantitative nutritional biomarker is available. The measurement of plasma fatty acids, often used as an alternative, is expensive and time-consuming. As meat and fish differ in their stable isotope ratios, δ(13)C and δ(15)N have been proposed as biomarkers. However, they have never been investigated in controlled human dietary intervention studies. OBJECTIVE: In a short-term feeding study, we investigated the suitability of δ(13)C and δ(15)N in blood, urine and faeces as biomarkers of meat and fish intake. METHODS: The dietary intervention study (n = 14) followed a randomised cross-over design with three eight-day dietary periods (meat, fish and half-meat-half-fish). In addition, 4 participants completed a vegetarian control period. At the end of each period, 24-h urine, fasting venous blood and faeces were collected and their δ(13)C and δ(15)N analysed. RESULTS: There was a significant difference between diets in isotope ratios in faeces and urine samples, but not in blood samples (Kruskal-Wallis test, p < 0.0001). In pairwise comparisons, δ(13)C and δ(15)N were significantly higher in urine and faecal samples following a fish diet when compared with all other diets, and significantly lower following a vegetarian diet. There was no significant difference in isotope ratio between meat and half-meat-half-fish diets for blood, urine or faecal samples. CONCLUSIONS: The results of this study show that urinary and faecal δ(13)C and δ(15)N are suitable candidate biomarkers for short-term meat and fish intake.
Assuntos
Biomarcadores/urina , Isótopos de Carbono/urina , Fezes/química , Comportamento Alimentar , Carne , Isótopos de Nitrogênio/urina , Adulto , Animais , Biomarcadores/sangue , Isótopos de Carbono/sangue , Estudos Cross-Over , Dieta Vegetariana , Feminino , Peixes , Humanos , Masculino , Isótopos de Nitrogênio/sangue , Avaliação Nutricional , Fatores de Risco , Autorrelato , Adulto JovemAssuntos
Anabolizantes/urina , Isótopos de Carbono/urina , Doping nos Esportes , Cromatografia Gasosa-Espectrometria de Massas , Substâncias para Melhoria do Desempenho/urina , Esteroides/urina , Detecção do Abuso de Substâncias/métodos , Biomarcadores/urina , Cromatografia Gasosa-Espectrometria de Massas/normas , Humanos , Valor Preditivo dos Testes , Controle de Qualidade , Reprodutibilidade dos Testes , Detecção do Abuso de Substâncias/normasRESUMO
Glucocorticoids are listed on the World Anti-Doping Agency (WADA) Prohibited List of substances. The detection of the administration of hydrocortisone and cortisone is complicated by the fact that the human body also produces these steroids naturally. Gas chromatography-combustion-isotope ratio mass spectrometry can be utilized to determine the use of endogenous glucocorticoids by measuring the carbon isotope ratio (CIR) of their resulting metabolites in human urine samples. A comprehensive sample preparation protocol for the analysis of endogenous glucocorticoid urinary metabolites was developed and validated, incorporating the use of high performance liquid chromatography (HPLC) for purification and chemical oxidation for derivatisation. Target compounds were tetrahydrocortisol and tetrahydrocortisone, and 11ß-hydroxyetiocholanolone, 11-oxoetiocholanolone and 11ß-hydroxyandrosterone, while pregnanediol functioned as the endogenous reference compound. Urine samples from a population of 50 volunteers were analyzed to determine CIR reference limits. Excretion studies of the endogenous glucocorticoid preparation cortisone acetate (25 mg oral) and the dietary supplement adrenosterone (75 mg oral) were conducted with six male individuals. Variable changes in steroid metabolite isotopic composition were found across subjects after administration. The study also revealed that CIR analysis of the major glucocorticoid metabolites tetrahydrocortisol and tetrahydrocortisone is necessary to unambiguously distinguish administration of cortisone and adrenosterone, the former officially restricted to out-of-competition use by athletes, the latter not being restricted at the current time. Moreover, this study reaffirms that CIR methods for the doping control of endogenous steroids should not rely upon a single ERC, as the administration of an appropriate precursor to that ERC could cause complications during analysis.
Assuntos
Androstenos/urina , Isótopos de Carbono/urina , Cortisona/análogos & derivados , Doping nos Esportes , Cromatografia Gasosa-Espectrometria de Massas , Glucocorticoides/urina , Substâncias para Melhoria do Desempenho/urina , Detecção do Abuso de Substâncias/métodos , Administração Oral , Adulto , Androstenos/administração & dosagem , Biomarcadores/urina , Biotransformação , Calibragem , Cromatografia Líquida de Alta Pressão , Cortisona/administração & dosagem , Cortisona/urina , Cromatografia Gasosa-Espectrometria de Massas/normas , Glucocorticoides/administração & dosagem , Humanos , Limite de Detecção , Masculino , Oxirredução , Substâncias para Melhoria do Desempenho/administração & dosagem , Valor Preditivo dos Testes , Valores de Referência , Reprodutibilidade dos Testes , Detecção do Abuso de Substâncias/normas , Adulto JovemRESUMO
Δ(13)C and δ(13)C values of endogenous urinary steroids represent physiological random variables. Measurement uncertainty and biological scatter likewise contribute to the variances. The statistical distributions of negative controls are well investigated, but there is little knowledge about the corresponding distributions of steroid-users. For these reasons valid discrimination of steroid users from non-users by (13)C/(12)C analysis of endogenous steroids requires elaborate statistical treatment. Corresponding Bayesian approaches are presented following an introduction to the rationale. The use of mixture models appears appropriate. The distribution of routine data has been deconvolved and characterized accordingly. The mixture components, which presumably represent steroid users and non-users, exhibit considerable overlap. The validity of a given result depends on both the analytical uncertainty and the prior probability of doping offenses. Low analytical uncertainties but high prior probabilities facilitate valid detection of doping offenses. Two recommendations can be deduced. First, before starting an (13)C/(12)C analysis, any initial suspicion should be well-substantiated. This precludes use of permissive criteria derived from the steroid profile. Secondly, knowledge of relevant (13)C/(12)C distributions is required. This must cover representative numbers of authentic steroid users. Finally, it is desirable that the conditional probability for steroid administration rather than the measurement uncertainty is calculated and reported. This quantity possesses superior validity and it is largely independent of laboratory bias. The findings suggest and facilitate flexible handling of decision limits. Proposals for the evaluation of stable isotope data are presented.
Assuntos
Anabolizantes/urina , Isótopos de Carbono/urina , Doping nos Esportes , Cromatografia Gasosa-Espectrometria de Massas , Substâncias para Melhoria do Desempenho/urina , Esteroides/urina , Detecção do Abuso de Substâncias/métodos , Teorema de Bayes , Biomarcadores/urina , Calibragem , Cromatografia Gasosa-Espectrometria de Massas/normas , Humanos , Modelos Estatísticos , Valor Preditivo dos Testes , Controle de Qualidade , Padrões de Referência , Reprodutibilidade dos Testes , Detecção do Abuso de Substâncias/normasRESUMO
The history of isotope ratio mass spectrometry (IRMS) is briefly described. It is shown that the fundamental design of isotope ratio mass spectrometers has not changed since the 1940s. The basic findings concerning the natural variation of isotope abundances even date back to the 1930s. Recent improvements in the methodology mainly concern online coupling and analytical peripherals. The nature of isotopic scales necessitates a specific terminology which is unfamiliar to many analysts. However, corresponding guidelines exist that should be adopted by the anti-doping community. Currently, steroids represent the only group of compounds routinely analyzed by IRMS in doping-control. Suggestions are made in respect to a harmonized terminology concerning the nature and origins of steroids.
Assuntos
Anabolizantes/urina , Isótopos de Carbono/urina , Doping nos Esportes , Cromatografia Gasosa-Espectrometria de Massas , Substâncias para Melhoria do Desempenho/urina , Esteroides/urina , Detecção do Abuso de Substâncias/métodos , Anabolizantes/classificação , Biomarcadores/urina , Isótopos de Carbono/história , Doping nos Esportes/história , Cromatografia Gasosa-Espectrometria de Massas/história , História do Século XX , História do Século XXI , Humanos , Substâncias para Melhoria do Desempenho/classificação , Substâncias para Melhoria do Desempenho/história , Valor Preditivo dos Testes , Esteroides/classificação , Detecção do Abuso de Substâncias/história , Terminologia como AssuntoRESUMO
The accuracy and precision of gas chromatography combustion isotope ratio mass spectrometry (GC-C-IRMS) measurements are highly dependent on analyte purity. Reliable analysis of urinary steroids for doping control therefore requires extensive and time-consuming sample preparation (i.e. liquid chromatography fraction collection) prior to GC-C-IRMS analysis. The use of two-dimensional GC (GC-GC) with heart-cutting (Deans Switch) as a possible approach to reduce the sample purification required for IRMS analysis is described herein. The system uses a low thermal mass oven (LTM) incorporated into an existing GC-C-IRMS system. GC-GC allowed the use of a cyanopropyl/phenyl column in the first dimension to optimize the separation of underivatized steroids, while a phenyl-methylpolysiloxane column in the second dimension focuses the selectively cut analytes into narrower peaks for more sensitive and reliable MS analysis. In addition, to confirm analyte identity, eluent from the second GC was split, with 20 % entering a scanning MS, and 80 % flowing to the IRMS. As a proof concept, the developed method was then used to analyze a single spot urine (5 ml) from an individual receiving T therapy (2 × 50 mg sachets of Testogel(®)). The T delta value (-27.8 , [T] = 38 ng/ml) was clearly distinct from 11-ketoetiocholanolone (-22.5 ) (used as an endogenous reference compound (ERC)), indicating T as being of exogenous origin. The simultaneous analysis by the scanning MS yielded a full scan mass spectrum of the same chromatographic peak, thus confirming the peak to be T.
Assuntos
Anabolizantes/urina , Isótopos de Carbono/urina , Doping nos Esportes , Cromatografia Gasosa-Espectrometria de Massas , Substâncias para Melhoria do Desempenho/urina , Detecção do Abuso de Substâncias/métodos , Testosterona/urina , Anabolizantes/administração & dosagem , Biomarcadores/urina , Calibragem , Desenho de Equipamento , Cromatografia Gasosa-Espectrometria de Massas/instrumentação , Cromatografia Gasosa-Espectrometria de Massas/normas , Humanos , Limite de Detecção , Técnicas Analíticas Microfluídicas , Substâncias para Melhoria do Desempenho/administração & dosagem , Valor Preditivo dos Testes , Valores de Referência , Reprodutibilidade dos Testes , Detecção do Abuso de Substâncias/instrumentação , Detecção do Abuso de Substâncias/normas , Testosterona/administração & dosagemRESUMO
The detection of steroids originating from synthetic precursors against a background of their chemically identical natural analogues has proven to be a significant challenge for doping control laboratories accredited by the World Anti-Doping Agency (WADA). The complementary application of gas chromatography-mass spectrometry (GC-MS) and gas chromatography-combustion-isotope ratio mass spectrometry (GC-C-IRMS) has been demonstrated to provide specific detection of endogenous steroid misuse for improved anti-doping analysis. Markers of synthetically derived steroids are reviewed on the basis of abnormal urinary excretions and low (13)C content. A combinatorial approach is presented for the interpretation of GC-MS and GC-C-IRMS data in the anti-doping context. This methodology can allow all relevant information concerning an individual's metabolism to be assessed in order to make an informed decision with respect to a doping violation.
Assuntos
Anabolizantes/urina , Isótopos de Carbono/urina , Doping nos Esportes , Cromatografia Gasosa-Espectrometria de Massas , Substâncias para Melhoria do Desempenho/urina , Esteroides/urina , Detecção do Abuso de Substâncias/métodos , Biomarcadores/urina , Biotransformação , Técnicas de Química Combinatória , Humanos , Valor Preditivo dos TestesRESUMO
An accurate method for the measurement of carbon isotope ratios of steroids in human urine has been developed at the National Measurement Institute, Australia (NMIA) for the certification of a freeze-dried human urine reference material (CRM NMIA MX005). The method measures δ(13)C values by gas chromatography-combustion-isotope ratio mass spectrometry (GC-C-IRMS) analysis following hydrolysis, solvent extraction and high performance liquid chromatography (HPLC) purification. Reference δ(13)C values for testosterone metabolites etiocholanolone, androsterone, and endogenous reference compounds (ERCs) 11ß-hydroxyandrosterone and pregnanediol were determined, as well as information δ(13)C values for testosterone, epitestosterone, 11-oxoetiocholanolone, and a range of differences (Δ(13)C) between testosterone metabolites and ERCs. The measurement uncertainty was rigorously evaluated with expanded uncertainties for the reference δ(13)C values between 1.1 and 1.6 at the 95% coverage level.